BioSpace News Archive

Masimo and Philips Licensing Agreement Brings Masimo NomoLine ® Capnography and O3 ® Regional Oximetry to Select Philips Patient Monitors

New company brand identity and Chief Scientific Officer appointment reflect long-term focus on developing small molecule therapeutics that regulate conformation of challenging drug targets SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )-- Biodesy Inc. today announced that it has changed its corporate name to BlueLight Therapeutics Inc. , effective May 20, 2020, and appointed drug discovery expert Mark Gallop, PhD, as Chief Scientific Officer. The new

Sensei Biotherapeutics , Inc., a clinical-stage biopharmaceutical company developing precision immuno-oncology therapies, today announced the acquisition of Alvaxa Biosciences, Inc., a camelid antibody therapeutics company with technology licensed from Fred Hutchinson Cance

Veracyte, Inc . (Nasdaq: VCYT) announced today that Bonnie H. Anderson, chairman and chief executive officer, is scheduled to present virtually at the William Blair 40th Annual Growth Stock Conference on Wednesday, June 10, at 12:40 p.m. Central Time. The link to the live audio webcast of the company’s presentation will be available by visiting Veracyte’s website at https://investor.veracyte.com/events-

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines to create a new generation of transformative medicines for patients, announced its participation in the following upcoming virtual investor conferences:

ALR Technologies, Inc. (“ALRT”) (OTCQB: ALRT), the diabetes management company, has signed agreements with clinics of Centrus Health Kansas City to conduct a clinical pilot. Four Centrus Health Kansas City primary care clinics will participate in the pilot: AdventHealth Medical Group, Clay-Platte Family Medicine Clinic, Northland Family Care and one other clinic. The pilot will demonstrate the clinical usefulness of the ALRT Diabetes Solution i

EarlySense, the global leader in contact-free, continuous monitoring solutions for the healthcare continuum, announced it is one of the strategic medical technologies chosen by Sheba Medical Center for their new COVID-19 inspired immersive simulation patient room of the future.

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced that President and Chief Executive Officer, Cameron Reynolds has been invited to present at The Role of Cell Therapy and Clarity on Testing Conference organised by the Maxim Group. Event Details: Wednesday, May 27 , 10am-2pm U.S. Eastern Time 10am Introductio

AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and cannabinoid research, announced today it has expanded its research division through the establishment of a state-of-the-art laboratory in the biotechnology industry hub of San Diego, Calif. Additionally, respected scientist Dr. Sergei Svarovsky will lead the oncology-focused research team as

Arcutis Biotherapeutics, Inc., a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, announced that Jay Ramsinghani has joined the company as Vice President of Commercial Strategy and Operations.